SYNGENE - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 20 Dec 25, 03:55 pm

Technical Rating: 3.7

📊 Chart Patterns: SYNGENE is trading above its 50 DMA (644 ₹) but slightly below its 200 DMA (672 ₹). Support lies near 599 ₹, while resistance is around 672–700 ₹. The broader chart suggests consolidation with a mild bullish undertone.

📈 Moving Averages: Current price (655 ₹) is above the 50 DMA but below the 200 DMA, indicating short-term strength but medium-term resistance.

📉 RSI: At 57.3, RSI is neutral to slightly bullish, suggesting moderate momentum without being overbought.

📈 MACD: Positive (1.83), showing bullish crossover and potential for upward momentum.

📊 Bollinger Bands: Price is near the mid-band, indicating consolidation. A breakout above 672 ₹ could trigger momentum toward 700 ₹.

📊 Volume Trends: Current volume (9,60,566) is higher than average weekly volume (7,79,202), showing strong participation and accumulation interest.

🚦 Momentum Signals: Short-term momentum is mildly bullish. Sustained move above 672 ₹ is required for confirmation of trend reversal.

🎯 Entry Zone: 640–650 ₹ (near 50 DMA support).

🎯 Exit Zone: 680–700 ₹ (resistance zone).

📌 Trend Status: The stock is consolidating with bullish undertone, awaiting breakout above resistance.

Positive

• Strong ROCE (12.8%) and ROE (9.78%) indicate efficient capital usage.
• Low debt-to-equity ratio (0.07) ensures financial stability.
• DII holdings increased by 0.57%, reflecting domestic institutional support.

Limitation

• High P/E (60.3) compared to industry average (46.0) suggests overvaluation.
• PEG ratio of 46.8 indicates expensive growth prospects.
• Quarterly profit variation (-31.5%) shows slowing earnings momentum.

Company Negative News

• PAT declined from 74 Cr. to 66.2 Cr. sequentially.
• FII holdings decreased by -0.20%, showing reduced foreign investor confidence.

Company Positive News

• DII holdings increased, showing domestic institutional confidence.
• EPS of 10.9 ₹ reflects consistent earnings despite quarterly slowdown.

Industry

• Industry P/E at 46.0 indicates moderate valuation compared to SYNGENE’s elevated levels.
• Biotech and pharma sector remains supported by global demand for research and innovation.

Conclusion

⚖️ SYNGENE is consolidating with bullish undertone, trading above 50 DMA but below 200 DMA. Short-term traders may consider entry near 640–650 ₹ with exit around 680–700 ₹. Long-term investors should be cautious due to high valuations and slowing profit growth, but strong fundamentals and low debt provide resilience.